Trials / Completed
CompletedNCT05237830
Effectiveness of Intraoperative Cell Salvage in Aseptic Revision Total Hip Arthroplasty.
Effectiveness of Intraoperative Cell Salvage in Aseptic Revision Total Hip Arthroplasty: a Single-center Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (actual)
- Sponsor
- University of Liege · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Intraoperative cell salvage is an important measure of patient blood management but its effectiveness in patients undergoing revision total hip arthroplasty remains unclear. Over the last decade, we have used intraoperative cell salvage systematically in this group of patients. However, since the use of cell salvage has a cost and requires additional resources, we decided to retrospectively investigate its usefulness in this particular indication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Use of Cell Salvage in revision of total hip arthroplasty | The effective use of the cell saver was defined as the ability to re-transfuse at least 125 mL of re-suspended red blood cells with a hematocrit of 60 %. |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2021-12-31
- Completion
- 2022-01-31
- First posted
- 2022-02-14
- Last updated
- 2022-02-14
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05237830. Inclusion in this directory is not an endorsement.